Literature DB >> 7389260

Kinetics of R andS warfarin enantiomers.

C Hignite, J Uetrecht, C Tschanz, D Azarnoff.   

Abstract

A method is reported for simultaneous measurement of the kinetics of R and S warfarin enantiomers. Pure pentadeuterated R and S enantiomers were each combined with unlabeled enatiomers to form "pseudo"-racemic mixtures which were given (0.75 mg/kg) to 5 healthy subjects. Plasma R and S enantiomer levels were measured by gas chromatography--mass spectrometry. Elimination half-lifes (t1/2S) and volumes of distribution (VdS) of the enantiomers were not altered by the presence of the other.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7389260     DOI: 10.1038/clpt.1980.137

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  7 in total

Review 1.  Application of stable labelled drugs in clinical pharmacokinetic investigations.

Authors:  M Eichelbaum; G E von Unruh; A Somogyi
Journal:  Clin Pharmacokinet       Date:  1982 Nov-Dec       Impact factor: 6.447

2.  Effect of gemfibrozil on the pharmacokinetics and pharmacodynamics of racemic warfarin in healthy subjects.

Authors:  Jari J Lilja; Janne T Backman; Pertti J Neuvonen
Journal:  Br J Clin Pharmacol       Date:  2005-04       Impact factor: 4.335

3.  The measurement of warfarin enantiomers in serum using coupled achiral/chiral, high-performance liquid chromatography (HPLC).

Authors:  Y Q Chu; I W Wainer
Journal:  Pharm Res       Date:  1988-10       Impact factor: 4.200

Review 4.  Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship.

Authors:  N H Holford
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

Review 5.  Clinical pharmacokinetic considerations in the control of oral anticoagulant therapy.

Authors:  H G Shetty; A G Fennerty; P A Routledge
Journal:  Clin Pharmacokinet       Date:  1989-04       Impact factor: 6.447

Review 6.  Pharmacology of anticoagulants used in the treatment of venous thromboembolism.

Authors:  Edith A Nutescu; Allison Burnett; John Fanikos; Sarah Spinler; Ann Wittkowsky
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

7.  Erratum to: Pharmacology of anticoagulants used in the treatment of venous thromboembolism.

Authors:  Edith A Nutescu; Allison Burnett; John Fanikos; Sarah Spinler; Ann Wittkowsky
Journal:  J Thromb Thrombolysis       Date:  2016-08       Impact factor: 2.300

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.